arrow
Back
M

Martin H. Voss

Memorial Sloan Kettering Cancer Center

55H-index
567Paper Count
2.3WCitation Count
Published Papers 108
Publication Date
From diversity to function: microbiome precision in RCC
err2026-04-08
err0
PREAI
errAntonio Ocejo; Ritesh R. Kotecha; Martin H. Voss
errShare
errSave
Mechanistic insights make cancer cachexia a targetable syndrome
err2026-01-02
err0
PREAI
errEd Reznik; Martin H. Voss; A. Ari Hakimi
errShare
errSave
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers
err2025-12-13
err0
errOAAI
errRana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
errShare
errSave
Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy alone
err2025-12-01
err0
PREAI
errBarbakoff, Daniel; Dawidek, Mark T.; Knezevic, Andrea; Ganz, Marc; Posada, Lina; Khandwala, Yash; Sanmiguel, Andrea Lopez; Reese, Stephen W.; Oparanozie, Arnold; Liso, Nicole; Kotecha, Ritesh R.; Motzer, Robert J.; Reznik, Ed; Coleman, Jonathan; Ostrovnaya, Irina; Voss, Martin H.; Russo, Paul; Hakimi, A. Ari
errShare
errSave
Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma
err2025-11-26
err0
PREAI
errYash S. Khandwala; Stephen W. Reese; Burcin A. Ucpinar; Andrea Knezevic; Lennert Eismann; Chih-Ying Wu; Rohan Mittal; Sahil Doshi; Daniel Barbakoff; Andrea Lopez Sanmiguel; Jonathan Coleman; Mark Dawidek; Robert J. Motzer; Paul Russo; Oguz Akin; Ritesh R. Kotecha; Ying-Bei Chen; Martin H. Voss; A. Ari Hakimi
errShare
errSave
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell Carcinoma
err2025-11-04
err0
PREAI
errMark T. Dawidek; Lina Posada Calderon; Parantu K. Shah; Rohan Mittal; Burcin Agridag Ucpinar; Ziad Bakouny; Kevin Meli; Eddy Saad; Renée-Maria Saliby; H. Jun Woo; Yash S. Khandwala; Marc Eid; Chris Labaki; Marc Machaalani; Jonathan Coleman; Paul Russo; Ritesh R. Kotecha; Maria I. Carlo; Oguz Akin; David A. Braun; Toni K. Choueiri; Ed Reznik; Ying-Bei Chen; Robert J. Motzer; Martin H. Voss; A. Ari Hakimi
errShare
errSave
Radiomic biomarkers associated with immune checkpoint blockade response for advanced renal cell carcinoma
err2025-11-01
err0
PREAI
errReese, Stephen W.; Barbakoff, Daniel; Ucpinar, Burcin Agridag; Knezevic, Andrea; Fitzgerald, Kelly; Eismann, Lennert; Tehrani, Yousef Mazaheri; Arroyave, Juan Sebastian; Khaleel, Sari; Khandwala, Yash S.; Dawidek, Mark; Motzer, Robert J.; Voss, Martin H.; Russo, Paul; Akin, Oguz; Kotecha, Ritesh R.; Hakimi, A. Ari
errShare
errSave
Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling
err2025-10-30
err0
errOAAI
errPavlos Msaouel; Nizar M. Tannir; Funda Meric-Bernstam; Jennifer M. King; Martin H. Voss; Jessica P. Cheng; Susan S. Thomas; Zita D. Lim; Menuka Karki; Rong He; Giannicola Genovese; Rahul A. Sheth; Davis R. Ingram; Diana Shamsutdinova; Khalida M. Wani; Wei-Lien Wang; Alexander J. Lazar; Dominique Knipper-Davis; Amber Berlinski; Tayla Soares; Danil Stupichev; Kirill Kryukov; Suren Davitavyan; Anna Novokreshchenova; Dmitry Lebedev; Stanislav Kurpe; Andrey Kravets; Dmitrii Belousov; Michael Hensley; Alexander Bagaev; Francesca Paradiso; Vladimir Kushnarev
errShare
errSave
Subgroup analysis of the efficacy and safety of cabozantinib ± atezolizumab in patients from CONTACT-03 who received first-line treatment with immuno-oncology-based combinations
err2025-10-01
err0
errOAAI
errMcgregor, Bradley A.; Suarez, Cristina; Choueri, Toni; Albiges, Laurence; Voss, Martin; Khan, Omara; Williamson, Denise; Ricardo Perez, Jose; Hall, Tasha; Pal, Sumanta
errShare
errSave
Pembrolizumab plus lenvatinib for previously untreated advanced non-clear cell renal cell carcinoma: 3-year follow-up of the phase 2 KEYNOTE-B61 study
err2025-10-01
err2
errOAAI
errAlbiges, Laurence; Gurney, Howard; Lee, Jae Lyun; Atduev, Vagif; Suarez, Cristina; Climent, Miguel A.; Pook, David; Tomczak, Piotr; Barthelemy, Philippe; Gedye, Craig; Lacombe, Louis; Ferguson, Thomas; Stus, Viktor; Wiechno, Pawel; Erman, Mustafa; Urun, Yuksel; Cornell, Jerry; Burgents, Joe; Sharma, Manish; Voss, Martin
errShare
errSave
Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank
err2025-09-01
err0
PREAI
errShapiro, Daniel D.; Abel, Edwin Jason; Albiges, Laurence; Battle, Dena; Berg, Stephanie A.; Campbell, Matthew T.; Cella, David; Coleman, Katie; Garmezy, Benjamin; Geynisman, Daniel M.; Hall, Tasha; Henske, Elizabeth P.; Jonasch, Eric; Karam, Jose A.; La Rosa, Salvatore; Leibovich, Bradley C.; Maranchie, Jodi K.; Master, Viraj A.; Maughan, Benjamin L.; Mcgregor, Bradley A.; Msaouel, Pavlos; Pal, Sumanta K.; Perez, Jose; Plimack, Elizabeth R.; Psutka, Sarah P.; Riaz, Irbaz B.; Rini, Brian I.; Shuch, Brian; Simon, Marie Celeste; Singer, Eric A.; Smith, Andrew; Staehler, Michael; Tang, Chad; Tannir, Nizar M.; Vaishampayan, Ulka; Voss, Martin H.; Zakharia, Yousef; Zhang, Qing; Zhang, Tian; Carlo, Maria I.
errShare
errSave
First-line Pembrolizumab Plus Lenvatinib for Advanced Non–clear-cell Renal Cell Carcinoma: Updated Results from the Phase 2 KEYNOTE-B61 Trial
err2025-07-24
err0
PREAI
errMartin H. Voss; Howard Gurney; Vagif Atduev; Cristina Suarez; Miguel A. Climent; David Pook; Piotr Tomczak; Philippe Barthélémy; Jae Lyun Lee; Taron Nalbandian; Viktor Stus; Thomas Ferguson; Pawel Wiechno; Erhan Gokmen; Louis Lacombe; Craig Gedye; Jerry Cornell; Manish Sharma; Joseph E. Burgents; Laurence Albiges
errShare
errSave
Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma
err2025-06-01
err0
PREAI
errBeckermann, Kathryn E.; Shah, Neil J.; Campbell, Matthew T.; Haas, Naomi B.; Nelson, Ariel; Ornstein, Moshe C.; Mao, Shifeng; Keshava-Prasad, Holavanahalli S.; Hammers, Hans; Gao, Xin; Gourdin, Theodore; George, Saby; Hoimes, Christopher J.; Hussain, Arif; Jonasch, Eric; Rini, Brian, I; Voss, Martin H.
errShare
errSave
A Phase 1b/2 Study of Talazoparib and Axitinib in Patients with Advanced Clear-cell Renal Cell Carcinoma
err2025-03-29
err0
PREAI
errRitesh R. Kotecha; Sahil D. Doshi; Andrea Knezevic; Rachel Jacobi; Hyung Jun Woo; David H. Aggen; Deaglan J. McHugh; Neil J. Shah; Maria I. Carlo; Niamh M. Keegan; Yogini Gayadin; Joshua Chaim; Mark T.A. Donoghue; Gopa Iyer; Chung-Han Lee; Darren R. Feldman; Robert J. Motzer; Martin H. Voss
errShare
errSave
Clinicopathologic and Molecular Features Associated with Chromophobe Renal Cell Carcinoma Progression
err2025-03-01
err0
PREAI
errRammal, Rayan; Chen, Jie-Fu; Al-Ahmadie, Hikmat; Fine, Samson; Gopalan, Anuradha; Sarungbam, Judy; Tickoo, Satish; Hakimi, A.; Voss, Martin; Reuter, Victor; Chen, Ying-Bei
errShare
errSave
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial (vol 86, pg 90, 2024)
err2025-01-01
err0
PREAI
errFitzgerald, Kelly N.; Lee, Chung-Han; Voss, Martin H.; Carlo, Maria I.; Knezevic, Andrea; Peralta, Laura; Chen, Yingbei; Lefkowitz, Robert A.; Shah, Neil J.; Owens, Colette N.; Mchugh, Deaglan J.; Aggen, David H.; Laccetti, Andrew L.; Kotecha, Ritesh R.; Feldman, Darren R.; Motzer, Robert J.
errShare
errSave
Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase 2 Trial
err2024-08-01
err2
PREAI
errFitzgerald, Kelly N.; Lee, Chung-Han; Voss, Martin H.; Carlo, Maria I.; Knezevic, Andrea; Peralta, Laura; Chen, Yingbei; Lefkowitz, Robert A.; Shah, Neil J.; Owens, Colette N.; Mchugh, Deaglan J.; Aggen, David H.; Laccetti, Andrew L.; Kotecha, Ritesh R.; Feldman, Darren R.; Motzer, Robert J.
errShare
errSave
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer
err2024-08-01
err1
PREAI
errKotecha, Ritesh R.; Doshi, Sahil D.; Knezevic, Andrea; Chaim, Joshua; Chen, Yingbei; Jacobi, Rachel; Zucker, Mark; Reznik, Ed; McHugh, Deaglan; Shah, Neil J.; Feld, Emily; Aggen, David H.; Rafelson, William; Xiao, Han; Carlo, Maria I.; Feldman, Darren R.; Lee, Chung-Han; Motzer, Robert J.; Voss, Martin H.
errShare
errSave
Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery
err2024-08-01
err0
PREAI
errJennifer Ma; Luke del Balzo; Henry Walch; Sari Khaleel; Andrea Knezevic; Jessica Flynn; Zhigang Zhang; Jordan Eichholz; Sahil D. Doshi; Martin H. Voss; Benjamin Freeman; A. Ari Hakimi; Chung-Han Lee; Tejus A. Bale; Daniel Kelly; Boris A. Mueller; Justin Mann; Yao Yu; Melissa Zinovoy; Linda Chen; John Cuaron; Atif Khan; Yoshiya Yamada; Jacob Y. Shin; Kathryn Beal; Nelson S. Moss; Maria I. Carlo; Robert J. Motzer; Brandon S. Imber; Ritesh R. Kotecha; Luke R.G. Pike
errShare
errSave